Moving towards tissue-agnostic antibody drug conjugates: HER2 expression as the poster child

Ann Oncol. 2023 Nov;34(11):968-969. doi: 10.1016/j.annonc.2023.10.115.

Authors

R Abelman¹, L M Spring¹, R Corcoran¹, A Bardia²

Affiliations

¹ Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
² Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Bardia.Aditya@mgh.harvard.edu.

PMID: 37996170
DOI: 10.1016/j.annonc.2023.10.115

No abstract available

Publication types

Editorial

MeSH terms

Child
Humans
Immunoconjugates* / therapeutic use
Receptor, ErbB-2 / metabolism
Trastuzumab / therapeutic use

Substances

Immunoconjugates
Trastuzumab
Receptor, ErbB-2